1. Baker, J. E., Contney, S. J., Singh, R., Kalyanaraman, B., Gross, G. J., and Bosnjak, Z. J., Nitric oxide activates the sarcolemmal KATP channel in normoxic and chronically hypoxic heart by a cyclic GMP-dependent mechanism.J. Mol. Cell Cardiol., 33, 331–341 (2001).
2. Bradamante, S., Barenghi, L., Piccinini, F., Bertelli, A.A.E., De Jonge, R., Beemster, P., and De Jong, J.W., Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.Eur. J. Pharmacol., 465, 115–123 (2003).
3. Brady, A. J., Warren, J. B., Poole-Wilson, P. A., Williams, T. J., and Harding, S. E., Nitric oxide attenuates cardiac myocyte contraction.Am. J. Physiol., 265, H176-H182 (1993).
4. Buluc, M. and Demirel-Yilmaz, E., Possible mechanism for depression of smooth muscle tone by resveratrol. In: Adv. Rec. Cardiovas. Res. Ed.: A. Varro, A. Vegh. Monduzzi Editore, Bologna, Italy, pp. 55–59, (2002).
5. Buluc, M. and Demirel-Yilmaz, E., Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium.Vas. Pharmacol., 44(4), 231–237(2006).